TY - JOUR
T1 - Association of maternal whole blood fatty acid status during the prenatal period with term birth dimensions
T2 - A cross-sectional study
AU - Jia, Xiaofang
AU - Tagawa, Masahiro
AU - Yatsuya, Hiroshi
AU - Naito, Hisao
AU - Hayashi, Yumi
AU - Yetti, Husna
AU - Sasaki, Seiko
AU - Araki, Atsuko
AU - Miyashita, Chihiro
AU - Ikeno, Tamiko
AU - Kishi, Reiko
AU - Nakajima, Tamie
N1 - Publisher Copyright:
© 2015 by De Gruyter.
PY - 2015/9/1
Y1 - 2015/9/1
N2 - To investigate selected fatty acid (FA) profiles in maternal whole blood during normal pregnancy and to evaluate their associations with term birth dimensions. Methods: We characterized nine major maternal blood FAs representing four FA families during the second and third trimester of pregnancy, and explored their associations with birth weight, length, and chest or head circumferences by multivariate regression models, using data from 318 mother-newborn pairs of the Hokkaido Study. Results: The absolute and/or relative contents of maternal blood docosahexaenoic acid and arachidonic acid were lowest at 35-41 gestational weeks during pregnancy, as was the essential FA status index. Different from palmitic and stearic acids, palmitoleic and oleic acid contents were higher at 35-41 gestational weeks than those at 23-31 gestational weeks. Three FA components were identified through principal component analysis, and were used in association analysis. Component 3, which was positively and significantly loaded by eicosapentaenoic acid (EPA), was associated with chest circumference [β=0.281, 95% confidence interval (CI): 0.006, 0.556] at 35-41 gestational weeks (P=0.046). No significant associations were observed for Component 1 and 2 loaded by FAs except EPA. Conclusion: Maternal blood EPA content may have an important influence on infant chest circumference.
AB - To investigate selected fatty acid (FA) profiles in maternal whole blood during normal pregnancy and to evaluate their associations with term birth dimensions. Methods: We characterized nine major maternal blood FAs representing four FA families during the second and third trimester of pregnancy, and explored their associations with birth weight, length, and chest or head circumferences by multivariate regression models, using data from 318 mother-newborn pairs of the Hokkaido Study. Results: The absolute and/or relative contents of maternal blood docosahexaenoic acid and arachidonic acid were lowest at 35-41 gestational weeks during pregnancy, as was the essential FA status index. Different from palmitic and stearic acids, palmitoleic and oleic acid contents were higher at 35-41 gestational weeks than those at 23-31 gestational weeks. Three FA components were identified through principal component analysis, and were used in association analysis. Component 3, which was positively and significantly loaded by eicosapentaenoic acid (EPA), was associated with chest circumference [β=0.281, 95% confidence interval (CI): 0.006, 0.556] at 35-41 gestational weeks (P=0.046). No significant associations were observed for Component 1 and 2 loaded by FAs except EPA. Conclusion: Maternal blood EPA content may have an important influence on infant chest circumference.
UR - http://www.scopus.com/inward/record.url?scp=84941054337&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84941054337&partnerID=8YFLogxK
U2 - 10.1515/jpm-2014-0277
DO - 10.1515/jpm-2014-0277
M3 - Article
C2 - 25485613
AN - SCOPUS:84941054337
SN - 0300-5577
VL - 43
SP - 565
EP - 575
JO - Journal of Perinatal Medicine
JF - Journal of Perinatal Medicine
IS - 5
ER -